DNLI vs KEYS · $2.11B cap vs P/E 57, rev $4.98B
Denali Therapeutics Inc (DNLI) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
DNLI currently screens at market cap $2.11B. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the DNLI and KEYS stock pages for the full models.
Not investment advice.